“Translational research in blood disease .
The purpose of the start-up is to quickly find new treatments against chronic lymphocytic leukemia B cells initially through the use of immunostimulatory compounds and cytotoxic compounds specifically targeting diseased cells. The goal is to improve the lives of maximum patient comfort by reducing the negative side effects associated with heavy chemotherapies currently on the market.

Take contact

Type de structure :
Address: 45 rue Clémenceau
29403 Landivisiau Cedex